• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Corticosteroids in adults with acute respiratory distress syndrome and severe pneumonia.成人急性呼吸窘迫综合征和重症肺炎患者使用皮质类固醇的情况。
BJA Educ. 2023 Dec;23(12):456-463. doi: 10.1016/j.bjae.2023.08.005. Epub 2023 Oct 19.
2
Low-Dose Corticosteroids for Critically Ill Adults With Severe Pulmonary Infections: A Review.低剂量皮质类固醇治疗重症肺部感染的危重症成人：系统评价。
JAMA. 2024 Jul 23;332(4):318-328. doi: 10.1001/jama.2024.6096.
3
COVID-19 in Lung Transplant Recipients: 2 Cases With Acute Respiratory Distress Syndrome Successfully Treated With High-Dose Corticosteroids.肺移植受者中的 COVID-19：2 例急性呼吸窘迫综合征患者成功接受大剂量皮质类固醇治疗。
Exp Clin Transplant. 2021 Jul;19(7):744-748. doi: 10.6002/ect.2021.0007. Epub 2021 Jun 3.
4
Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.基于 COVID-19、其他冠状病毒感染、流感、社区获得性肺炎和急性呼吸窘迫综合征的证据评估 COVID-19 中皮质类固醇的疗效和安全性：系统评价和荟萃分析。
CMAJ. 2020 Jul 6;192(27):E756-E767. doi: 10.1503/cmaj.200645. Epub 2020 May 14.
5
Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: a meta-analysis of randomized controlled trials.糖皮质激素治疗急性肺损伤、急性呼吸窘迫综合征和重症肺炎：一项随机对照试验的荟萃分析。
J Crit Care. 2010 Sep;25(3):420-35. doi: 10.1016/j.jcrc.2009.08.009. Epub 2009 Nov 5.
6
Preadmission Oral Corticosteroids Are Associated With Reduced Risk of Acute Respiratory Distress Syndrome in Critically Ill Adults With Sepsis.入院前口服皮质类固醇与脓毒症成年危重症患者急性呼吸窘迫综合征风险降低相关。
Crit Care Med. 2017 May;45(5):774-780. doi: 10.1097/CCM.0000000000002286.
7
The influence of prehospital systemic corticosteroid use on development of acute respiratory distress syndrome and hospital outcomes.院前全身皮质类固醇的使用对急性呼吸窘迫综合征的发展和医院转归的影响。
Crit Care Med. 2013 Jul;41(7):1679-85. doi: 10.1097/CCM.0b013e31828a1fc7.
8
Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial.COVID-19 肺炎无急性低氧性呼吸衰竭患者早期使用地塞米松治疗的效果及急性呼吸窘迫综合征的发生风险（EARLY-DEX COVID-19）：一项随机对照试验的研究方案。
Trials. 2022 Sep 15;23(1):784. doi: 10.1186/s13063-022-06722-x.
9
Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome.皮质类固醇、COVID-19 肺炎和急性呼吸窘迫综合征。
J Clin Invest. 2020 Dec 1;130(12):6218-6221. doi: 10.1172/JCI143331.
10
Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome.重症甲型 H1N1 流感肺炎和急性呼吸窘迫综合征患者早期应用皮质类固醇。
Am J Respir Crit Care Med. 2011 May 1;183(9):1200-6. doi: 10.1164/rccm.201101-0135OC. Epub 2011 Mar 4.

引用本文的文献

1
Corticosteroids and long-term pulmonary function after critical illness due to COVID-19- a single-center cohort study.皮质类固醇与新型冠状病毒肺炎危重症后的长期肺功能——一项单中心队列研究
BMC Pulm Med. 2025 Apr 26;25(1):201. doi: 10.1186/s12890-025-03659-0.
2
Causes and management of impaired gas exchange in critically ill patients.危重症患者气体交换受损的原因及处理
BJA Educ. 2025 Mar;25(3):90-98. doi: 10.1016/j.bjae.2024.11.001. Epub 2025 Jan 3.
3
Clinical and biologic profiles of patients with acute respiratory distress syndrome by prevalence of chronic obstructive pulmonary disease or emphysema; a cohort study.急性呼吸窘迫综合征患者中慢性阻塞性肺疾病或肺气肿患病率的临床和生物学特征；一项队列研究。
Respir Res. 2024 Nov 8;25(1):400. doi: 10.1186/s12931-024-03027-2.

本文引用的文献

1
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies.急性呼吸窘迫综合征 ESICM 指南：定义、表型和呼吸支持策略。
Intensive Care Med. 2023 Jul;49(7):727-759. doi: 10.1007/s00134-023-07050-7. Epub 2023 Jun 16.
2
Dead-Space Ventilation Indices and Mortality in Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis.急性呼吸窘迫综合征的死腔通气指数与死亡率：系统评价和荟萃分析。
Crit Care Med. 2023 Oct 1;51(10):1363-1372. doi: 10.1097/CCM.0000000000005921. Epub 2023 May 19.
3
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.COVID-19 住院患者中接受皮质类固醇治疗：一项随机、对照、开放标签、平台试验
Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13.
4
Hydrocortisone in Severe Community-Acquired Pneumonia.严重社区获得性肺炎的氢化可的松治疗。
N Engl J Med. 2023 May 25;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Epub 2023 Mar 21.
5
Mechanisms of impaired alveolar fluid clearance.肺泡液体清除受损的机制。
Anat Rec (Hoboken). 2025 Apr;308(4):1026-1039. doi: 10.1002/ar.25166. Epub 2023 Jan 23.
6
Higher- versus Lower-Dose Corticosteroids for Severe to Critical COVID-19: A Systematic Review and Dose-Response Meta-analysis.高剂量与低剂量皮质类固醇治疗重症至危重新冠肺炎：系统评价和剂量反应荟萃分析。
Ann Am Thorac Soc. 2023 Apr;20(4):596-604. doi: 10.1513/AnnalsATS.202208-720OC.
7
Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia.危重症社区获得性肺炎患者的小剂量甲基强的松龙治疗。
Intensive Care Med. 2022 Aug;48(8):1009-1023. doi: 10.1007/s00134-022-06684-3. Epub 2022 May 13.
8
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial.地塞米松 12 毫克对比 6 毫克治疗 COVID-19 伴严重低氧血症患者：COVID-STEROID 2 试验的预先计划的二次贝叶斯分析。
Intensive Care Med. 2022 Jan;48(1):45-55. doi: 10.1007/s00134-021-06573-1. Epub 2021 Nov 10.
9
Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.地塞米松 12 毫克与 6 毫克对 COVID-19 合并严重低氧血症成人患者存活无生命支持天数的影响：COVID 类固醇 2 随机试验。
JAMA. 2021 Nov 9;326(18):1807-1817. doi: 10.1001/jama.2021.18295.
10
Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease.特发性机化性肺炎：一种神秘肺部疾病的最新认识。
Eur Respir Rev. 2021 Aug 17;30(161). doi: 10.1183/16000617.0094-2021. Print 2021 Sep 30.

Corticosteroids in adults with acute respiratory distress syndrome and severe pneumonia.

作者信息

Jayasimhan D, Matthay M A

机构信息

Wellington Regional Hospital, Wellington, New Zealand.

University of California-San Francisco, San Francisco, CA, USA.

出版信息

BJA Educ. 2023 Dec;23(12):456-463. doi: 10.1016/j.bjae.2023.08.005. Epub 2023 Oct 19.

DOI:10.1016/j.bjae.2023.08.005
PMID:38009137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10667747/
Abstract
摘要